Presentation TCT 2016 Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies Presenter: Richard Smalling November 01, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 PFO/ASD Up Next Presentation TCT 2016 What Should Be the Next Series of Clinical Trials in PFO Closure? Presenter: John D. Carroll November 01, 2016 More slides + Presentation TCT 2016 Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do? Presenter: Robert J. Sommer November 01, 2016 Presentation TCT 2016 CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Presenter: Anand Prasad November 01, 2016 We Recommend
Presentation TCT 2016 What Should Be the Next Series of Clinical Trials in PFO Closure? Presenter: John D. Carroll November 01, 2016
Presentation TCT 2016 Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do? Presenter: Robert J. Sommer November 01, 2016
Presentation TCT 2016 CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Presenter: Anand Prasad November 01, 2016